What drove today’s move in PRFN.SW stock?

PRFN.SW stock fell on 06 Mar 2026 after heavy trading. Volume was **2,937,350**, 3.42x the average. The jump in activity likely reflected speculative flows and thin liquidity rather than company filings.

What is Meyka AI’s grade for PRFN.SW stock and what it means?

Meyka AI rates PRFN.SW **62.90** out of 100, Grade **B**, **HOLD**. The score blends benchmark, sector, financials, key metrics, and analyst signals. It is informational and not investment advice.

What price targets and forecast exist for PRFN.SW stock?

Meyka AI's forecast model projects a short-term target near **CHF 0.075** (≈+107.18%) and a 12-month scenario at **CHF 0.12** (≈+231.49%). Forecasts are model projections, not guarantees.

How risky is trading PRFN.SW stock on SIX?

PRFN.SW stock is high risk due to low market cap, thin disclosure, and volatile intraday moves. Cash per share is small and liquidity can swing, so strict risk limits matter for traders and investors.

CH Stocks

PRFN.SW Kinarus (SIX) -8.12% to CHF0.0362 06 Mar 2026: heavy volume insight

ByDanny Kontos March 7, 2026

PRFN.SW stock closed sharply lower on 06 Mar 2026 after heavy trading. Kinarus Therapeutics Holding AG (PRFN.SW) ended the session at CHF 0.0362, down 8.12% from yesterday, on a volume of 2,937,350 shares. The move left the share price below its 50-day average (CHF 0.07275) and 200-day average (CHF 0.07420). The market closed with a high intraday range between CHF 0.0352 and CHF 0.04, and a relative volume of 3.42, flagging this as one of the most active Swiss small-caps today